Generate a tailored SOP for Dr. Miffy Cheng. Improve your application with a focused, well-structured draft.
Miffy Hok Yan Cheng is an Assistant Professor at the University of British Columbia's Faculty of Pharmaceutical Sciences, leading the Lipid Nanoparticle-Enabled Gene Delivery (LEGenD) lab. Dr. Cheng's research focuses on developing innovative nanomedicine approaches, especially lipid nanoparticles for gene therapy targeting chronic diseases. Her work employs a transdisciplinary approach integrating synthetic chemistry, biophysics, and molecular imaging to enhance patient outcomes with safer, more effective cancer therapies. Dr. Cheng has a solid academic background with a BSc from the University of Hull and a PhD in Chemistry, during which she created novel bioconjugate systems. Her postdoctoral training at the Princess Margaret Cancer Research Centre and UBC expanded her expertise in nanoengineering and mRNA delivery systems. She has received multiple awards including the CIHR REDI Early Career Transition Award, the Michael John Page Postdoctoral Fellow Award, and various research grants. Dr. Cheng is dedicated to advancing cancer research and mentoring aspiring scientists in the field of nanomedicine.
University of British Columbia • Vancouver, BC, Canada
Leading the LEGenD lab and conducting research in nanomedicine.
Offers course-only and thesis routes. Focus areas include philosophy of science, mind, ethics, and Asian philosophy.